Victoza in Canada: liraglutide for type 2 diabetes

Victoza at a glance

A prescription liraglutide product authorized for type 2 diabetes under its current monograph. It is not the liraglutide brand authorized for chronic weight management.^[1]

Victoza’s diabetes role is not Saxenda’s indication

Victoza and Saxenda share liraglutide but have different authorized uses. The ingredient guide explains the shared mechanism without collapsing the products.

A brand name, ingredient and indication should all be explicit when checking a prescription or insurance rule. None can safely stand in for the others.^[1][2]

Assessment should retain the diabetes and cardiovascular context

A diabetes assessment connects current treatment, glucose goals, cardiovascular context where applicable, other medicines, medical history and follow-up. If weight management is the main question, state it directly so the clinician can assess relevant options.

Use the Victoza DIN when verifying access

Health Canada’s DPD listed Victoza DIN 02351064 as Marketed when checked August 14, 2026. That lifecycle label is not a local-stock report and does not establish reimbursement.

Give the exact DIN and prescribed indication to the payer through the coverage workflow. Then ask a pharmacy for the total cash price using the same-product quote method rather than substituting a Saxenda or generic liraglutide price.^[2][3][4]